Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A bankerBig Pharma will increase acquisitions in 2025 due to patent expirations of major drugs.
CG Life doubles in size by buying a digital shop to expand its health and sciences targetingCG Life acquired Toolhouse to expand tech and omnichannel capabilities in health and biopharma space.Private equity-backed companies are bringing competition and innovation to the life science agency sector.